Mirum Pharmaceuticals grants chief medical officer Myers 40,000 stock options
MIRM•Mirum Pharmaceuticals granted Chief Medical Officer Robert Paul Myers 40,000 stock options and 25,000 restricted stock units on Oct. 9, 2026; the options expire Oct. 8, 2036.
1. Equity awards
Mirum Pharmaceuticals granted Chief Medical Officer Robert Paul Myers 40,000 employee stock options and 25,000 restricted stock units on Oct. 9, 2026. The options expire on Oct. 8, 2036.
